Ventyx Biosciences Statistics
Total Valuation
VTYX has a market cap or net worth of $82.51 million. The enterprise value is -$159.64 million.
Important Dates
The next estimated earnings date is Thursday, May 8, 2025, after market close.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
VTYX has 71.13 million shares outstanding. The number of shares has increased by 16.97% in one year.
| Current Share Class | 71.13M |
| Shares Outstanding | 71.13M |
| Shares Change (YoY) | +16.97% |
| Shares Change (QoQ) | +0.20% |
| Owned by Insiders (%) | 4.58% |
| Owned by Institutions (%) | 66.28% |
| Float | 54.96M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.32 |
| P/TBV Ratio | 0.32 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 17.97, with a Debt / Equity ratio of 0.04.
| Current Ratio | 17.97 |
| Quick Ratio | 17.09 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -54.27% and return on invested capital (ROIC) is -35.60%.
| Return on Equity (ROE) | -54.27% |
| Return on Assets (ROA) | -33.48% |
| Return on Invested Capital (ROIC) | -35.60% |
| Return on Capital Employed (ROCE) | -56.28% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.65M |
| Employee Count | 82 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -73.26% in the last 52 weeks. The beta is 0.75, so VTYX's price volatility has been lower than the market average.
| Beta (5Y) | 0.75 |
| 52-Week Price Change | -73.26% |
| 50-Day Moving Average | 1.33 |
| 200-Day Moving Average | 2.02 |
| Relative Strength Index (RSI) | 49.59 |
| Average Volume (20 Days) | 1,332,852 |
Short Selling Information
The latest short interest is 7.35 million, so 10.33% of the outstanding shares have been sold short.
| Short Interest | 7.35M |
| Short Previous Month | 6.91M |
| Short % of Shares Out | 10.33% |
| Short % of Float | 13.38% |
| Short Ratio (days to cover) | 9.62 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -148.45M |
| Pretax Income | -171.30M |
| Net Income | -135.12M |
| EBITDA | -148.18M |
| EBIT | -148.45M |
| Earnings Per Share (EPS) | -$1.97 |
Full Income StatementBalance Sheet
The company has $217.32 million in cash and $10.79 million in debt, giving a net cash position of $242.15 million or $3.40 per share.
| Cash & Cash Equivalents | 217.32M |
| Total Debt | 10.79M |
| Net Cash | 242.15M |
| Net Cash Per Share | $3.40 |
| Equity (Book Value) | 254.05M |
| Book Value Per Share | 3.57 |
| Working Capital | 216.85M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$130.87 million and capital expenditures -$241,000, giving a free cash flow of -$131.11 million.
| Operating Cash Flow | -130.87M |
| Capital Expenditures | -241,000 |
| Free Cash Flow | -131.11M |
| FCF Per Share | -$1.84 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |